Citations

Mayo Clinic

Showing 10 of 108599 citations.

Multifocal Extramedullary Plasma Cell Myeloma of the Colon
Karime, Christian , Sileno, Sean, Pisipati, Sailaja , Lam‐Himlin, Dora , Umar, Sarah B. , Sileno, Sean M, Lam-Himlin, Dora M

ACG Case Reports Journal | July 6, 2023 | Volume: 10 | Issue: 7 | Pages: e01081

10.14309/crj.0000000000001081 | PMID 37426567 Get It

Machine learning can accurately predict risk factors for all‐cause reoperation after ACLR: creating a clinical tool to improve patient counseling and outcomes
Johnson, Quinn J. , Jabal, Mohamed Sobhi , Arguello, Alexandra M. , Jurgensmeier, Kevin , Levy, Bruce A. , Krych, Aaron J. , Jabal, Mohamed S, Krych, Aaron J , Jurgensmeier, Kevin , Lu, Yining , Camp, Christopher L.

Knee Surgery, Sports Traumatology, Arthroscopy | July 6, 2023 | Volume: 31 | Issue: 10 | Pages: 4099-4108

10.1007/s00167-023-07497-7 | PMID 37414947 Get It

AbstractPurposeIdentifying predictive factors for all‐cause reoperation after anterior cruciate ligament reconstruction could inform clinical decision making and improve risk mitigation. The primary purposes of this study are to (1) determine the incidence of all‐cause reoperation after anterior cruciate ligament reconstruction, (2) identify predictors of reoperation after anterior cruciate ligament reconstruction using machine learning methodology, and (3) compare the predictive capacity of the machine learning methods to that of traditional logistic regression.MethodsA longitudinal geographical database was utilized to identify patients with a diagnosis of new anterior cruciate ligament injury. Eight machine learning models were appraised on their ability to predict all‐cause reoperation after anterior cruciate ligament reconstruction. Model performance was evaluated via area under the receiver operating characteristics curve. To explore modeling interpretability and radiomic feature influence on the predictions, we utilized a game‐theory‐based method through SHapley Additive exPlanations.ResultsA total of 1400 patients underwent anterior cruciate ligament reconstruction with a mean postoperative follow‐up of 9 years. Two‐hundred and eighteen (16%) patients experienced a reoperation after anterior cruciate ligament reconstruction, of which 6% of these were revision ACL reconstruction. SHapley Additive exPlanations plots identified the following risk factors as predictive for all‐cause reoperation: diagnosis of systemic inflammatory disease, distal tear location, concomitant medial collateral ligament repair, higher visual analog scale pain score prior to surgery, hamstring autograft, tibial fixation via radial expansion device, younger age at initial injury, and concomitant meniscal repair. Pertinent negatives, when compared to previous studies, included sex and timing of surgery. XGBoost was the best‐performing model (area under the receiver operating characteristics curve of 0.77) and outperformed logistic regression in this regard.ConclusionsAll‐cause reoperation after anterior cruciate ligament reconstruction occurred at a rate of 16%. Machine learning models outperformed traditional statistics and identified diagnosis of systemic inflammatory disease, distal tear location, concomitant medial collateral ligament repair, higher visual analog scale pain score prior to surgery, hamstring autograft, tibial fixation via radial expansion device, younger age at initial injury, and concomitant meniscal repair as predictive risk factors for reoperation. Pertinent negatives, when compared to previous studies, included sex and timing of surgery. These models will allow surgeons to tabulate individualized risk for future reoperation for patients undergoing anterior cruciate ligament reconstruction.Level of evidenceIII.
Analysis of Hairline and Forehead Sexual Dimorphic Aesthetics in 60 Celebrities Using Artificial Intelligence
Salinas, Cristina A., Liu, Alice , Sharaf, Basel , Sharaf, Basel A, Sharaf, Basel A

Plastic and Reconstructive Surgery - Global Open | July 6, 2023 | Volume: 11 | Issue: 7 | Pages: e5107

10.1097/gox.0000000000005107 | PMID 37427151 Get It

Background: Upper facial third morphometrics are an important consideration in aesthetic facial surgery and facial gender-affirming surgery. Although there are generally accepted sexual dimorphic differences, an in-depth analysis of forehead morphometrics in attractive individuals is lacking. Methods: Thirty white female and 30 white male celebrities were included. Three full-face front-view photographs of each celebrity were evaluated by a facial analysis program, using Vision framework and MATLAB. After converting pixel distances to absolute distances, midline and lateral forehead heights were calculated and compared between men and women. Results: Forehead height was similar between attractive men and women, but forehead width was shorter in women. Analysis of forehead height at various points along the hairline demonstrated that forehead measurements above the lateral brow and brow peak were significantly greater in men. Mean forehead height above the lateral eyebrow was 3.51 cm in women and 4.16 cm in men (P = 0.017). Forehead height above the eyebrow peak was 4.34 cm in women and 5.55 cm in men (P < 0.001). Medial forehead height was similar between men and women, indicating that the greatest difference in attractive male and female foreheads is in the lateral forehead and forehead width. Conclusions: Analysis of attractive white celebrities demonstrated no significant differences in central forehead heights between men and women. Forehead width and lateral forehead height were significantly smaller in women, with an overall downward slanting contour. Male hairlines were more horizontal and slanting upward laterally. These results have implications in facial rejuvenation and facial gender-affirming surgery.
Size Threshold Surveillance—A Revised Approach to Wait-and-Scan for Vestibular Schwannoma
Marinelli, John P. , Link, Michael J. , Carlson, Matthew L.

JAMA Otolaryngology–Head & Neck Surgery | July 6, 2023 | Volume: 149 | Issue: 8 | Pages: 657

10.1001/jamaoto.2023.1427 | PMID 37410485 Get It

This Viewpoint discusses how recent discoveries surrounding the natural history of sporadic vestibular schwannoma provide data to support a shift in current management paradigms.
Radiosynthesis and Preliminary Evaluation of [11C]SSI-4 for the Positron Emission Tomography Imaging of Stearoyl CoA Desaturase 1
Li, Kang‐Po , Gleba, Justyna J., Copland, John A. , Cai, Hancheng , Trynda, Justyna , Cai, Hancheng , Gleba, Justyna , Parent, Ephraim E. , Knight, Joshua A.

Molecular Pharmaceutics | July 6, 2023 | Volume: 20 | Issue: 8 | Pages: 4129-4137

10.1021/acs.molpharmaceut.3c00273 | PMID 37409698 Get It

DIPNECH: pragmatic approach, uncertainties, notable associations, and a proposal for an improved definition
Samhouri, Bilal F. , Hálfdánarson, Þorvarður R. , Koo, Chi Wan , McCarthy, Cormac , Yi, Eunhee S. , Thomas, Charles F., Ryu, Jay H. , Halfdanarson, Thorvardur R , Ryu, Jay H

Endocrine-Related Cancer | July 6, 2023 | Volume: 30 | Issue: 10 | Pages: No page available

10.1530/erc-23-0051 | PMID 37410394 Get It

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare, but increasingly recognized entity that primarily affects middle-aged and elderly women. It is characterized by abnormal proliferation of pulmonary neuroendocrine cells (PNECs) and is considered a preinvasive lesion for carcinoid tumorlets/tumors. Sometimes, DIPNECH is accompanied by constrictive bronchiolitis which usually manifests as chronic cough and/or dyspnea, along with airflow limitation on spirometry. The telltale imaging sign of DIPNECH is the presence of multiple noncalcified pulmonary nodules and mosaic attenuation on CT. However, these clinico-radiologic features of DIPNECH are characteristic but nonspecific; thus, histopathologic confirmation is usually necessary. DIPNECH has an indolent course and only rarely leads to respiratory failure or death; progression to overt neuroendocrine tumor (carcinoid) of the lung occurs in a minority of patients. Of available therapies, somatostatin analogs and mechanistic target of rapamycin inhibitors are the most promising. In this review, we provide an update regarding the diagnosis and management of DIPNECH and describe critical gaps in our understanding of this entity, including the central terms ‘diffuse’ and ‘idiopathic.’ We also summarize the inconsistencies in definitions employed by recent studies and discuss the pitfalls of the DIPNECH definitions proposed by the World Health Organization in 2021. In this context, we propose an objective and reproducible radio-pathologic case definition intended for implementation in the research realm and seeks to enhance homogeneity across cohorts. Furthermore, we discuss aspects of PNECs biology which suggest that PNEC hyperplasia may contribute to the pathogenesis of phenotypes of lung disease aside from constrictive bronchiolitis and carcinoid tumorlets/tumors. Finally, we steer attention to some of the most pressing and impactful research questions awaiting to be unraveled.
Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials
Streck, Joanna M. , Lee, Ju‐Whei , Walter, Angela Wangari , Rosen, Rachel , Gareen, Ilana F. , Kircher, Sheetal Mehta , Herman, B. , Carlos, Ruth C. , Kumar, Shaji , Mayer, Ingrid A. , Fenske, Timothy S. , Neal, Joel W. , Hodi, F. Stephen , Kyriakopoulos, Christos E. , Tempany, Clare M. , Shanafelt, Tait D. , Mayer, IA , Rosen, Rachel L , Herman, Benjamin A , Saba, Nabil F , Fenske, Timothy S , Neal, Joel W , Atkins, Michael B. , Hodi, Frank Stephen , Kyriakopoulos, Christos E , Tempany, Clare , Shanafelt, Tait D , Wagner, Lynne , Land, Stephanie R , Park, Elyse R , Ostroff, Jamie S , Saba, Nabil F. , Wagner, Lynne I.

Cancer Epidemiology, Biomarkers & Prevention | July 6, 2023 | Volume: 32 | Issue: 11 | Pages: 1552-1557

10.1158/1055-9965.epi-23-0420 | PMID 37410096 Get It

Abstract Background: While cigarette smoking has declined among the U.S. general population, sale and use of non-cigarette alternative tobacco products (ATP; e.g., e-cigarettes, cigars) and dual use of cigarettes/ATPs are rising. Little is known about ATP use patterns in cancer survivors enrolled in clinical trials. We investigated prevalence of tobacco product use, and factors associated with past 30-day use, among patients with cancer in national trials. Methods: Cancer survivors (N = 756) enrolled in 9 ECOG-ACRIN clinical trials (2017–2021) completed a modified Cancer Patient Tobacco Use Questionnaire (C-TUQ) which assessed baseline cigarette and ATP use since cancer diagnosis and in the past 30 days. Results: Patients were on average 59 years old, 70% male, and the mean time since cancer diagnosis was 26 months. Since diagnosis, cigarettes (21%) were the most common tobacco product used, followed by smokeless tobacco use (5%), cigars (4%), and e-cigarettes (2%). In the past 30 days, 12% of patients reported smoking cigarettes, 4% cigars, 4% using smokeless tobacco, and 2% e-cigarettes. Since cancer diagnosis, 5.5% of the sample reported multiple tobacco product use, and 3.0% reported multiple product use in the past 30 days. Males (vs. females; OR 4.33; P = 0 &lt; 0.01) and individuals not living with another person who smokes (vs. living with; OR, 8.07; P = 0 &lt; 0.01) were more likely to use ATPs only versus cigarettes only in the past 30 days. Conclusions: Among patients with cancer, cigarettes were the most prevalent tobacco product reported. Impact: Regardless, ATPs and multiple tobacco product use should be routinely assessed in cancer care settings.
Aspiration Versus Stent‐Retriever as First‐Line Endovascular Therapy Technique for Primary Medium and Distal Intracranial Occlusions: A Propensity‐Score Matched Multicenter Analysis
Shaikh, Hamza , Khalife, Jane , Oak, Solomon , Abdalkader, Mohamad , Kass‐Hout, Tareq , Morsi, Rami Z. , Heit, Jeremy J. , Regenhardt, Robert W. , Diestro, Jose Danilo Bengzon , Ghozy, Sherief , Amllay, Abdelaziz , Dusart, Anne , Bellante, Flavio, Puri, Ajit S , Dyzmann, Christian , Kan, Peter , Berge, Jérôme , Barreau, Xavier , Nedelcu, Simona , Henninger, Nils , Marotta, Thomas R. , Stapleton, Christopher J. , Rabinov, James D. , Dofuku, Shogo , Capirossi, Carolina , Tjoumakaris, Stavropoula , Jabbour, Pascal , Khandelwal, Priyank , Biswas, Arundhati , Clarençon, Frédéric , Elhorany, Mahmoud , Premat, Kévin , Valente, Iacopo , Filipe, João Pedro , Varela, Ricardo , Quintero‐Consuegra, Miguel , Gonzalez, Nestor R. , Möhlenbruch, Markus , Costalat, Vincent , Chervak, Lina , Aziz, Yasmin , Bullrich, María Bres , Liebeskind, David S. , Alexandre, Andrea , Tancredi, Illario , Faizy, Tobias D. , Patel, Aman B. , Lubicz, Boris , Guenego, Adrien , Dmytriw, Adam A , Liebeskind, David S. , Heit, Jeremy J , Ghozy, Sherief , Diestro, Jose Danilo B , Gonzalez, Nestor R , Aziz, Yasmin , Regenhardt, Robert W , Henninger, Nils , Alexandre, Andrea M , Morsi, Rami Z , Varela, Ricardo , Siegler, James E. , Zhang, Linda , Klein, Piers , Nguyen, Thanh N. , Cancelliere, Nicole M , Sweid, Ahmad , Naamani, Kareem El , Meyer, Lukas , Forestier, Géraud , Rouchaud, Aymeric , Saleme, Suzana , Mounayer, Charbel , Fiehler, Jens , Kühn, Anna Luisa , Colasurdo, Marco , Marnat, Gaultier , Sibon, Igor , Das, Alvin S. , Ota, Takahiro , Yeo, Leonard Ll , Tan, Benjamin Yong‐Qiang , Martinez-Gutierrez, Juan Carlos , Salazar‐Marioni, Sergio , Sheth, Sunil A , Renieri, Leonardo , Mowla, Ashkan , Jabbour, Pascal , Khandelwal, Priyank , Pedicelli, Alessandro , Jesser, Jessica , Schiphorst, Adrien ter , Yedavalli, Vivek , Harker, Pablo , Sposato, Luciano A. , Gory, Benjamin , Hecker, Constantin , Killer-Oberpfalzer, Monika , Griessenauer, Christoph J. , Thomas, Ajith J , Hsieh, Cheng‐Yang , Radu, Răzvan Alexandru , Fahed, Robert , Weyland, Charlotte S. , Mendes Pereira, Vitor , Dmytriw, Adam A.

Stroke: Vascular and Interventional Neurology | July 6, 2023 | Volume: 3 | Issue: 6 | Pages: No page available

10.1161/svin.123.000931 | PMID 41585056 Get It

Background For acute proximal intracranial artery occlusions, contact aspiration may be more effective than stent‐retriever for first‐line reperfusion therapy. Due to the lack of data regarding medium vessel occlusion thrombectomy, we evaluated outcomes according to first‐line technique in a large, multicenter registry. Methods Imaging, procedural, and clinical outcomes of patients with acute proximal medium vessel occlusions (M2, A1, or P1) or distal medium vessel occlusions (M3, A2, P2, or further) treated at 37 sites in 10 countries were analyzed according to first‐line endovascular technique (stent‐retriever versus aspiration). Multivariable logistic regression and propensity‐score matching were used to estimate the odds of the primary outcome, expanded Thrombolysis in Cerebral Infarction score of 2b–3 (“successful recanalization”), as well as secondary outcomes (first‐pass effect, expanded Thrombolysis in Cerebral Infarction 2c‐3, intracerebral hemorrhage, and 90‐day modified Rankin scale, 90‐day mortality) between treatment groups. Results Of the 440 included patients (44.5% stent‐retriever versus 55.5% aspiration), those treated with stent‐retriever had lower baseline Alberta Stroke Program Early Computed Tomography Scale scores (median 8 versus 9; P <0.01), higher National Institutes of Health Stroke Scale scores (median 13 versus 11; P =0.02), and nonsignificantly fewer medium‐distal occlusions (M3, A2, P2, or other: 17.4% versus 23.8%; P =0.10). Use of a stent‐retriever was associated with 15% lower odds of successful recanalization (odds ratio [OR], 0.85; [95% CI 0.74–0.98]; P =0.02), but this was not significant after multivariable adjustment in the total cohort (adjusted OR, 0.88; [95% CI 0.72–1.09]; P =0.24), or in the propensity‐score matched cohort (n=105 in each group) (adjusted OR, 0.94; [95% CI 0.75–1.18]; P =0.60). There was no significant association between technique and secondary outcomes in the propensity‐score matched adjusted models. Conclusion In this large, diverse, multinational medium vessel occlusion cohort, we found no significant difference in imaging or clinical outcomes with aspiration versus stent‐retriever thrombectomy.
DiscoVari : A Web-Based Precision Medicine Tool for Predicting Variant Pathogenicity in Cardiomyopathy- and Channelopathy-Associated Genes
Kurzlechner, Leonie M. , Kishnani, Sujata, Chowdhury, Shawon, Atkins, S. , Moya‐Mendez, Mary E. , Rosamilia, Michael B. , Tadros, Hanna J. , Pace, Leslie, Patel, Viraj , Chahal, C. Anwar A. , Landstrom, Andrew P. , Rosamilia, Michael B , Tadros, Hanna J , Patel, Viraj , Chahal, Choudhary Anwar A , Landstrom, Andrew P , Parker, Lauren E.

Circulation: Genomic and Precision Medicine | July 6, 2023 | Volume: 16 | Issue: 4 | Pages: 317-327

10.1161/circgen.122.003911 | PMID 37409478 Get It

BACKGROUND: With genetic testing advancements, the burden of incidentally identified cardiac disease-associated gene variants is rising. These variants may carry a risk of sudden cardiac death, highlighting the need for accurate diagnostic interpretation. We sought to identify pathogenic hotspots in sudden cardiac death-associated genes using amino acid-level signal-to-noise (S:N) analysis and develop a web-based precision medicine tool, DiscoVari , to improve variant evaluation. METHODS: The minor allele frequency of putatively pathogenic variants was derived from cohort-based cardiomyopathy and channelopathy studies in the literature. We normalized disease-associated minor allele frequencies to rare variants in an ostensibly healthy population (Genome Aggregation Database) to calculate amino acid-level S:N. Amino acids with S:N above the gene-specific threshold were defined as hotspots. DiscoVari was built using JavaScript ES6 and using open-source JavaScript library ReactJS, web development framework Next.js, and JavaScript runtime NodeJS. We validated the ability of DiscoVari to identify pathogenic variants using variants from ClinVar and individuals clinically evaluated at the Duke University Hospitals with cardiac genetic testing. RESULTS: We developed DiscoVari as an internet-based tool for S:N-based variant hotspots. Upon validation, a higher proportion of ClinVar likely pathogenic/pathogenic variants localized to DiscoVari hotspots (43.1%) than likely benign/benign variants (17.8%; P< 0.0001). Further, 75.3% of ClinVar variants reclassified to likely pathogenic/pathogenic were in hotspots, compared with 41.3% of those reclassified as variants of uncertain significance ( P< 0.0001) and 23.4% of those reclassified as likely benign/benign ( P <0.0001). Of the clinical cohort variants, 73.1% of likely pathogenic/pathogenic were in hotspots, compared with 0.0% of likely benign/benign ( P< 0.01). CONCLUSIONS: DiscoVari reliably identifies disease-susceptible amino acid residues to evaluate variants by searching amino acid-specific S:N ratios.
American Radium Society Appropriate Use Criteria for the use of liver‐directed therapies for nonsurgical management of liver metastases: Systematic review and guidelines
Hallemeier, Christopher L. , Sharma, Navesh , Anker, Christopher J. , Lee, Percy, Williams, Vonetta M. , Kennedy, Timothy J., Jethwa, Krishan R. , Kumar, Rachit , Russo, Suzanne , Jethwa, Krishan , Small, William , Hallemeier, Christopher Leigh , Selfridge, Jennifer Eva , Lee, Percy , Jabbour, Salma K , Liu, David M. , Kim, Ed, Tchelebi, Leila T. , Russo, Suzanne

Cancer | July 6, 2023 | Volume: 129 | Issue: 20 | Pages: 3193-3212

10.1002/cncr.34931 | PMID 37409678 Get It

AbstractThe liver is a common site of cancer metastases. Systemic therapy is widely accepted as the standard treatment for liver metastases (LM), although select patients with liver oligometastases may be candidates for potentially curative liver resection. Recent data support the role of nonsurgical local therapies such as ablation, external beam radiotherapy, embolization, and hepatic artery infusion therapy for management of LM. Additionally, for patients with advanced, symptomatic LM, local therapies may provide palliative benefit. The American Radium Society gastrointestinal expert panel, including members representing radiation oncology, interventional radiology, surgical oncology, and medical oncology, performed a systemic review and developed Appropriate Use Criteria for the use of nonsurgical local therapies for LM. Preferred Reporting Items for Systematic reviews and Meta‐Analyses methodology was used. These studies were used to inform the expert panel, which then rated the appropriateness of various treatments in seven representative clinical scenarios through a well‐established consensus methodology (modified Delphi). A summary of recommendations is outlined to guide practitioners on the use of nonsurgical local therapies for patients with LM.